-
《A novel cell-free DNA methylationbased model improves the early detection of colorectal cancer》发表于《Molecular Oncology》(影响因子:6.6)
基准医疗与中山大学附属第六医院的兰平教授和吴现瑞教授团队在《Molecular Oncology》(影响因子:6.6)发布文章《A novel cell-free DNA methylationbased model improves the early detection of colorectal cancer》
-
《Diagnosis of pulmonary nodules by DNA methylation analysis in bronchoalveolar lavage fluids》发表于《Clinical Epigenetics》(影响因子:5.7)
基准医疗与华西医院刘丹及李为民课题组在《Clinical Epigenetics》(影响因子:5.7)发表《Diagnosis of pulmonary nodules by DNA methylation analysis in bronchoalveolar lavage fluids》
-
《A urine‑based DNA methylation assay to facilitate early detection and risk stratification of bladder cancer》发表于《Clinical Epigenetics》(影响因子:5.7)
基准医疗与中山大学孙逸仙纪念医院林天歆及黄健课题组在《Clinical Epigenetics》(影响因子:5.7)发表《A urine‑based DNA methylation assay to facilitate early detection and risk stratification of bladder cancer》
-
“钟声计划”的相关临床研究文章发表于国际领先学术期刊《Translational Lung Cancer Research》(影响因子:4.0)
基准医疗与国家呼吸医学中心钟南山院士团队,联合国内23家顶级医院开展的“钟声计划—ctDNA甲基化高通量检测用于肺部结节良恶性诊断和监测的临床研究(NCT03651986)”项目成果发表在国际领先学术期刊《Translational Lung Cancer Research》(影响因子:4.0)